We are live on
!
Find out more
OC
Oarsman Capital Portfolio holdings
AUM
$806M
1-Year Est. Return
19.96%
This Fund
S&P 500
This Quarter
Est. Return
+11.14%
1 Year Est. Return
+19.96%
3 Year Est. Return
+61.37%
5 Year Est. Return
+74.92%
10 Year Est. Return
+242.94%
AUM
$211M
AUM Growth
+$15.4M
(+7.9%)
Cap. Flow
-$3.72M
Cap. Flow
% of AUM
-1.77%
Top 10 Holdings %
Top 10 Hldgs %
22.58%
Holding
182
New
8
Increased
51
Reduced
94
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$1.43M |
| 2 |
UnitedHealth
UNH
|
+$888K |
| 3 |
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
|
+$813K |
| 4 |
ProShares Short S&P500
SH
|
+$558K |
| 5 |
State Street SPDR Portfolio Emerging Markets ETF
SPEM
|
+$484K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.35M |
| 2 |
MGIC Investment
MTG
|
+$1.23M |
| 3 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$1.11M |
| 4 |
AbbVie
ABBV
|
+$1.06M |
| 5 |
CVS Health
CVS
|
+$858K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.21% |
| 2 | Financials | 9.92% |
| 3 | Healthcare | 9.58% |
| 4 | Industrials | 7.64% |
| 5 | Consumer Discretionary | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$50.7B
| $6.74M | 3.2% |
181,034
+40,443
| +29% | +$1.43M |
|
2
iShares Core International Aggregate Bond Fund
IAGG
$10.6B
| $5.01M | 2.38% |
93,645
+7,129
| +8% | +$375K |
|
3
Microsoft
MSFT
$2.84T
| $4.81M | 2.29% |
40,804
+781
| +2% | +$85.2K |
|
4
Verizon
VZ
$194B
| $4.77M | 2.26% |
80,622
-335
| -0.4% | -$19K |
|
5
O-I Glass
OI
$1.39B
| $4.61M | 2.19% |
242,966
-5,429
| -2% | -$105K |
|
6
ATI
ATI
$27B
| $4.51M | 2.14% |
176,449
-2,035
| -1% | -$53.6K |
|
7
Johnson & Johnson
JNJ
$635B
| $4.41M | 2.1% |
31,575
+452
| +1% | +$60.5K |
|
8
Apple
AAPL
$4.89T
| $4.4M | 2.09% |
92,588
+3,972
| +4% | +$168K |
|
9
Alphabet (Google) Class C
GOOG
$3.9T
| $4.29M | 2.04% |
73,180
-260
| -0.4% | -$14.6K |
|
10
Citigroup
C
$222B
| $3.98M | 1.89% |
63,883
+366
| +0.6% | +$22.7K |
|
|
11
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.1B
| $3.91M | 1.86% |
129,033
+27,594
| +27% | +$813K |
|
|
12
MGIC Investment
MTG
$6.27B
| $3.82M | 1.81% |
289,385
-98,725
| -25% | -$1.23M |
|
13
JPMorgan Chase
JPM
$939B
| $3.55M | 1.69% |
35,083
+458
| +1% | +$47.2K |
|
|
FISV
14
Fiserv Inc
FISV
$27.2B
| $3.33M | 1.58% |
37,757
-1,755
| -4% | -$145K |
|
15
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.78B
| $3.07M | 1.46% |
107,520
+17,109
| +19% | +$480K |
|
16
Intel
INTC
$466B
| $2.94M | 1.4% |
54,773
-11,317
| -17% | -$574K |
|
17
Olin
OLN
$2.64B
| $2.92M | 1.39% |
126,418
+472
| +0.4% | +$11.3K |
|
18
Kohl's
KSS
$2.03B
| $2.76M | 1.31% |
40,157
+70
| +0.2% | +$4.75K |
|
|
19
ProShares Short S&P500
SH
$887M
| $2.74M | 1.3% |
24,787
+4,827
| +24% | +$558K |
|
20
Cisco
CSCO
$450B
| $2.71M | 1.28% |
50,094
-528
| -1% | -$25.7K |
|
|
21
AbbVie
ABBV
$458B
| $2.65M | 1.26% |
32,948
-12,989
| -28% | -$1.06M |
|
22
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$16.9B
| $2.65M | 1.26% |
87,719
+12,820
| +17% | +$381K |
|
|
23
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17B
| $2.63M | 1.25% |
73,542
+13,904
| +23% | +$484K |
|
|
24
CVS Health
CVS
$137B
| $2.53M | 1.2% |
46,906
-13,900
| -23% | -$858K |
|
25
Helen of Troy
HELE
$663M
| $2.49M | 1.18% |
21,477
-80
| -0.4% | -$9.22K |
|
Similar funds
RIM
BCM
GCM
CL
DWA
AF
OWA
BDWCC
Oarsman Capital's Q1 2019 Portfolio in Review
As of Q1 2019, Oarsman Capital held 182 positions worth $211M, up 7.9% from $195M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Oarsman Capital's Q1 2019 filing shows 8 new, 51 increased, 94 reduced and 5 closed positions. Its largest new stake was Madison Covered Call & Equity Strategy Fund: 42,406 shares worth $290K. The largest sale was Gilead Sciences, an estimated $1.35M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.
- Oarsman Capital's largest Q1 2019 buy was Madison Covered Call & Equity Strategy Fund: 42,406 shares worth $290K.
- Oarsman Capital added most to State Street SPDR Portfolio S&P 500 Growth ETF in Q1 2019, an estimated $1.43M increase.
- Oarsman Capital's biggest Q1 2019 reduction was Gilead Sciences, cutting an estimated $1.35M.
- Oarsman Capital fully exited Linde in Q1 2019, selling an estimated $289K.
- Oarsman Capital's ten largest holdings make up 23% of its $211M portfolio in Q1 2019.
- Oarsman Capital opened 8 new positions and closed 5 in Q1 2019.
- Oarsman Capital's portfolio value rose 7.9% quarter-over-quarter to $211M.
Based on Oarsman Capital's 13F filing for Q1 2019, filed 14 May 2019.